BioMarin Pharmaceutical Inc. trailing returns
BioMarin Pharmaceutical Inc.'s 10-year return is -4.7% a year (CAGR) (-38.2% cumulative). How BioMarin Pharmaceutical Inc. (BMRN) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-10-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | -2.2% | |
| 5 days | — | -5.1% | |
| 1 month | — | -14.6% | |
| YTD | — | -3.8% | |
| 1 year | +2.9% | +2.9% | |
| 5 years | -5.8% | -25.9% | |
| 10 years | -4.7% | -38.2% | |
| 20 years | +6.8% | +270.1% | |
| Since inception (1999) | +5.6% | +339.8% |
Growth of BMRN
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from BMRN's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is BioMarin Pharmaceutical Inc.'s 10-year return?
- Over the last 10 years, BioMarin Pharmaceutical Inc. (BMRN) returned about -4.7% a year annualized (-38.2% cumulative total return).
- What is BioMarin Pharmaceutical Inc.'s 20-year annualized return?
- Over the last 20 years, BioMarin Pharmaceutical Inc. (BMRN) compounded at about +6.8% a year (+270.1% cumulative).
- What is BioMarin Pharmaceutical Inc.'s return since inception?
- Since 1999, BioMarin Pharmaceutical Inc. (BMRN) has compounded at about +5.6% a year — +339.8% in total.